Cancer as an infectious disease: A different treatment alternative using a combination of tigecycline and pyrvinium pamoate - An example of breast cancer

CONCLUSION: Combining low dose of tigecycline use with pyrvinium pamoate is a novel approach for breast cancer treatment. Appropriate combined therapy in breast cancer is recommended to improve outcomes. Other problems like drug resistance occur in patients or the microbes surrounding breast tissues would confer susceptibility to cancers then influence the effectiveness of treatment, which could be improved through combined therapy.PMID:33610508 | DOI:10.1016/j.jmii.2020.12.008

Source: Journal of Microbiology, Immunology, and Infection - February 21, 2021 Category: Microbiology Authors: Shu-Wei Huang Ming-Tsung Sun Wen-Sen Lee Ying-Shih Su Yi-Tzu Lee Ming-Hsien Chiang Yung-Chih Wang Ya-Sung Yang Shian-Chiuan Tzeng Yu-Min Huang Feng-Huei Lin Source Type: research